BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

May 22, 2024 | News

Duoning Biotechnology and Bioelectronica Announce Strategic Partnership to Transform Antibody Discovery

Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess provider in China, today announced a strategic partnership with Bioelectronica,...

May 21, 2024 | News

Innovent Biologics' New Drug for Thyroid Eye Disease Granted Priority Review in China

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm...

May 21, 2024 | News

AstraZeneca Announces $1.5 Billion Manufacturing Facility in Singapore for Cutting-Edge Cancer Treatments

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...

May 20, 2024 | News

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

“Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said...

May 17, 2024 | News

Brii Biosciences Secures Breakthrough Therapy Designations for Two HBV Treatments from NMPA

Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need,...

May 14, 2024 | News

Arcellx and Kite Announce Phase 3 Trial for Anito-cel in Multiple Myeloma Patients

-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...

May 10, 2024 | News

Takara Bio USA Introduces Innovative Lenti-X Transduction Sponge for Gene Delivery

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market disso...

May 07, 2024 | News

Biocytogen Partners with BioCopy for TCR-Mimic Antibody Development

Biocytogen Pharmaceuticals, a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR-mimic antib...

May 07, 2024 | News

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

May 03, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

May 03, 2024 | News

Beckman Coulter Life Sciences Partners with Watchmaker Genomics to Enhance NGS Library Preparation Automation

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, a...

May 01, 2024 | News

Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies

The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...

May 01, 2024 | News

Asimov Launches New Cell Line Service, Expanding LV Edge System to Boost Therapeutic Production

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the la...

April 29, 2024 | News

Stay Connected